Absolute Lymphocyte Counts Are Not a Biomarker of Clinical Response in Patients Treated With Delayed-Release Dimethyl Fumarate

被引：0
|
作者：
Longbrake, Erin [1 ]
Mao-Draayer, Yang [2 ]
Matthews, Paul M. [3 ]
Foley, John [4 ]
Zielinski, Tomasz [5 ]
Chen, Chongshu [6 ]
Mokliatchouk, Oksana [6 ]
Parks, Becky [6 ]
Sharma, Ankur [6 ]
Xing, Diana [6 ]
Kapadia, Shivani [6 ]
Bame, Eris [6 ]
机构：
[1] Yale Univ, New Haven, CT 06520 USA
[2] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[3] Imperial Coll, London, England
[4] Rocky Mt Multiple Sclerosis Clin, Salt Lake City, UT USA
[5] NOVO MED, Katowice, Poland
[6] Biogen, Cambridge, MA USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
830
引用
收藏
页数：4
相关论文
共 50 条
  • [31] PATIENT CHARACTERISTICS AND TREATMENT ADHERENCE AMONG PATIENTS TREATED WITH DELAYED-RELEASE DIMETHYL FUMARATE FOR RELAPSING REMITTING MULTIPLE SCLEROSIS IN ISRAEL
    Desai, U.
    Huang, M.
    Kirson, N. Y.
    King, S.
    Hellstern, M.
    Schonfeld, S.
    Birnbaum, H. G.
    Lee, A.
    VALUE IN HEALTH, 2017, 20 (05) : A195 - A195
  • [32] Lymphocyte count reductions in relapsing-remitting multiple sclerosis (RRMS) patients treated with delayed-release dimethyl fumarate: integrated analysis of the placebo-controlled studies
    Fox, R. J.
    Chan, A.
    Gold, R.
    Phillips, J. T.
    Selmaj, K.
    Raghupathi, K.
    Yuan, H.
    O'Gorman, J.
    Novas, M.
    Viglietta, V.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 343 - 343
  • [33] Lymphocyte count reductions in relapsing-remitting multiple sclerosis (RRMS) patients treated with delayed-release dimethyl fumarate: integrated analysis of the placebo-controlled studies
    Fox, R. J.
    Chan, A.
    Gold, R.
    Phillips, J. T.
    Selmaj, K.
    Raghupathi, K.
    Yuan, H.
    O'Gorman, J.
    Novas, M.
    Viglietta, V.
    Kurukulasuriya, N. C.
    JOURNAL OF NEUROLOGY, 2014, 261 : S231 - S232
  • [34] Lymphocyte count reductions with delayed-release dimethyl fumarate: integrated analysis of the phase 2, phase 3, and extension studies
    Fox, R. J.
    Chan, A.
    Gold, R.
    Phillips, J. T.
    Selmaj, K.
    Zhang, R.
    Yuan, H.
    Novas, M.
    Viglietta, V.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 101 - 102
  • [35] Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis
    Alroughani, Raed
    Huppke, Peter
    Mazurkiewicz-Beldzinska, Maria
    Blaschek, Astrid
    Valis, Martin
    Aaen, Gregory
    Pultz, Joe
    Peng, Xiaomei
    Beynon, Vanessa
    FRONTIERS IN NEUROLOGY, 2021, 11
  • [36] Safety and effectiveness of delayed-release dimethyl fumarate in multiple sclerosis patients treated in routine medical practice: the first interim analysis of ESTEEM
    Everage, N. J.
    Prada, C.
    Liu, S.
    Balashov, K.
    Macdonell, R.
    Windsheimer, J.
    Giles, K.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 775 - 776
  • [37] Lymphopenia in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate: Analysis of Two United States Electronic Health Record Databases
    Wenten, Made
    Soman, Teesta
    Lally, Cathy
    Juneja, Maneesh
    Eaton, Susan
    Prada, Claudia
    Dilley, Anne
    NEUROLOGY, 2016, 86
  • [38] Delayed-release dimethyl fumarate and pregnancy: preclinical studies and pregnancy outcomes from clinical trials and postmarketing experience
    Li, J.
    Fox, R. J.
    Phillips, J. T.
    Havrdova, E.
    Bar-Or, A.
    Kappos, L.
    Kim, N.
    Valencia, P.
    Oliva, L.
    Novas, M.
    Gold, R.
    Rana, J.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 291 - 292
  • [39] Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience
    Gold R.
    Phillips J.T.
    Havrdova E.
    Bar-Or A.
    Kappos L.
    Kim N.
    Thullen T.
    Valencia P.
    Oliva L.
    Novas M.
    Li J.
    Sweetser M.T.
    Kurukulasuriya N.
    Viglietta V.
    Fox R.J.
    Neurology and Therapy, 2015, 4 (2) : 93 - 104
  • [40] Delayed-release dimethyl fumarate and pregnancy: preclinical studies and pregnancy outcomes from clinical trials and postmarketing experience
    Gold, R.
    Phillips, J. T.
    Havrdova, E.
    Bar-Or, A.
    Kappos, L.
    Yuan, H.
    Valencia, P.
    Oliva, L.
    Novas, M.
    Li, J.
    Sweetser, M. T.
    Kurukulasuriya, N. C.
    Viglietta, V.
    Fox, R. J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 435 - 435
12345